SCHEMBL30937481

SCHEMBL30937481

COc1ccncc1C=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 6/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
TSHR P16473 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
TLR2 O60603 1/20 0.43
TLR1 Q15399 1/20 0.43
TLR6 Q9Y2C9 1/20 0.43
MAPT P10636 1/20 0.42
PRKDC P78527 1/20 0.41
CYP1A1 P04798 3/20 0.41
CYP1A2 P05177 3/20 0.41
CYP1B1 Q16678 3/20 0.41
CYP2D6 P10635 2/20 0.41
CYP3A4 P08684 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1605930 1.00 ERN1 (0.49) ERN1CA12CA1CA2CA9
SCHEMBL6188476 0.91 CA12 (0.46) ERN1CA12CA1CA2CA9
SCHEMBL29935810 0.84 ERN1 (0.49) ERN1CA12CA1CA2CA9
SCHEMBL1052852 0.84 ERN1 (0.49) ERN1CA12CA1CA2CA9
SCHEMBL25403169 0.82 CA12 (0.46) CA12CA1CA2CA9ALDH1A1
SCHEMBL16096641 0.80 ALDH1A1 (0.38) ERN1CA12CA1CA2CA9
SCHEMBL26119644 0.79 ALDH1A3 (0.39) ERN1CA12CA1CA2CA9
SCHEMBL17895679 0.79 CA12 (0.53) CA12CA1CA2CA9ALDH1A1
SCHEMBL21484579 0.78 CYP3A4 (0.47) CA12CA1CA2CA9ALDH1A1
SCHEMBL26844605 0.78 SLC22A12 (0.51) ERN1ALDH1A1TSHRTDP1TLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4629988-A1 DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER AND INFECTIONS Centre National de la Recherche Scientifique (FR) 2025-10-15 EP disclosed
WO-2024121072-A1 DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER AND INFECTIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2024-06-13 WO disclosed